A carregar...
Assessment of the cardiac safety between cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory mCRC
OBJECTIVE: The cardiac safety of cetuximab and panitumumab, particularly as single agents, has not been investigated extensively. This trial was designed to specifically evaluate the cardiac safety of cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory metastatic colorecta...
Na minha lista:
| Publicado no: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5749385/ https://ncbi.nlm.nih.gov/pubmed/29343971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S149716 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|